Thrombocytopenia clinical trials at University of California Health

1 research study open to eligible people

Showing trials for

  • Clinical Performance Evaluation of T-TAS®01 HD Chip

    open to eligible people ages 18 years and up

    The study is being conducted to validate the clinical performance of the T-TAS 01 HD assay for measurement of thrombogenicity in patients with thrombocytopenia receiving a platelet transfusion.

    at UCSF

Last updated: